$GNPX

$2.21▲ +3.3% YTD

5 SEC 13D/G filings tracked · Last updated Nov 5, 2026

Filing History

CP $2.21▲ +3.3%Nov 5, 2026 · ThinkSabio Blog

$GNPX GNPX GNPX - Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Pa…

News

GNPX ▲ +3.1% - Genprex, Inc.

CP $2.36▲ +3.1%Nov 4, 2026 · ThinkSabio Blog

$GNPX GNPX GNPX - Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer…

News

GNPX ▲ +7.2% - Genprex, Inc.

CP $2.09▲ +7.2%Oct 28, 2026 · ThinkSabio Blog

$GNPX GNPX GNPX - Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America…

News

GNPX ▲ +8.5% - Genprex, Inc.

CP $2.31▲ +8.5%Oct 21, 2026 · ThinkSabio Blog

$GNPX GNPX GNPX - Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function Durin…

News

GNPX ▼ -2.0% - Genprex, Inc.

CP $3.43▲ -2.0%Sep 8, 2026 · ThinkSabio Blog

$GNPX GNPX GNPX - Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference…